| SHR (95% CI) | p-value |
---|---|---|
Mortality | Â | Â |
Derivation cohort (ref) | 1 | Â |
Validation cohort | 1.116 (0.911–1.365) | 0.289 |
node | ||
 1 | 0.306 (0.247–0.379) | <0.001 |
 2 | 0.855 (0.715–1.023) | 0.087 |
 3 | 0.756 (0.380–1.507) | 0.427 |
 4 | 0.115 (0.054–0.245) | <0.001 |
 5 | 0.565 (0.274–1.165) | 0.122 |
 6 | 0.982 (0.736–1.312) | 0.905 |
 7 (ref) | 1 |  |
interactions | ||
 V 1 | 1.702 (0.925–3.132) | 0.088 |
 V 2 | 0.872 (0.667–1.139) | 0.314 |
 V 3 | 1.258 (0.587–2.698) | 0.555 |
 V 4 | 0.526 (0.109–2.533) | 0.424 |
 V 5 | 0.930 (0.303–2.856) | 0.900 |
 V 6 | 0.873 (0.568–1.341) | 0.534 |
 V 7 (ref) | 1 |  |
RRT | ||
 | 1 |  |
Validation cohort | 1.162 (0.685–1.971) | 0.576 |
node | ||
 1 | 0.334 (0.226–0.493) | <0.001 |
 2 (ref) | 1 |  |
 3 | 3.441 (2.537–4.666) | <0.001 |
 4 | 0.975 (0.581–1-637) | 0.924 |
 5 | 1.002 (0.515–1.951) | 0.996 |
 6 | 0.391 (0.244–0.626) | <0.001 |
 7 | 0.441 (0.263–0.740) | 0.002 |
interactions | ||
 V 1 | 0.754 (0.380–1.499) | 0.421 |
 V 2 (ref) | 1 |  |
 V 3 | 0.572 (0.253–1.294) | 0.180 |
 V 4 | 0.442 (0.253–0.774) | 0.004 |
 V 5 | 0.229 (0.080–0.656) | 0.006 |
 V 6 | 0.383 (0.156–0.936) | 0.035 |
 V 7 | 0.389 (0.180–0.842) | 0.017 |